Category: DPP-4

Onglyza and Kombiglyze XR Excluded from Express Scripts 2016 Formulary Due to Safety Concerns

That means that patients using this drug may have to pay the full retail price for it. Why would the company refuse to help patients afford Onglyza? It has to do with recent warnings concerning potentially serious side effects associated with the drug. http://newyork.legalexaminer.com/fda-prescription-drugs/onglyza-and-kombiglyze-xr-excluded-from-express-scripts-2016-formulary-due-to-safety-concerns/